{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:32:49Z","timestamp":1754598769879},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12325-022-02246-7","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:02:42Z","timestamp":1658304162000},"page":"3871-3880","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brain Abnormalities in PIK3CA-Related Overgrowth Spectrum: Physician, Patient, and Caregiver Experiences"],"prefix":"10.1007","volume":"39","author":[{"given":"Joy","family":"Dexheimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghayda M.","family":"Mirzaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"issue":"1","key":"2246_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","volume":"16","author":"G Canaud","year":"2021","unstructured":"Canaud G, Hammill AM, Adams D, Vikkula M, Keppler-Noreuil KM. A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis. 2021;16(1):306. https:\/\/doi.org\/10.1186\/s13023-021-01929-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"suppl 5","key":"2246_CR2","doi-asserted-by":"publisher","first-page":"S1297","DOI":"10.1016\/j.annonc.2021.08.2097","volume":"32","author":"G Canaud","year":"2021","unstructured":"Canaud G, L\u00f3pez Guti\u00e9rrez JC, Irvine A, et al. Retrospective chart review study of patients with PIK3CA-related overgrowth spectrum (PROS) who have received alpelisib as part of a compassionate use programme. Ann Oncol. 2021;32(suppl 5):S1297. https:\/\/doi.org\/10.1016\/j.annonc.2021.08.2097 (Abstract LBA1223).","journal-title":"Ann Oncol"},{"key":"2246_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14027","author":"S Douzgou","year":"2021","unstructured":"Douzgou S, Rawson M, Baselga E, et al. A standard of care for individuals with PIK3CA-related disorders: an international expert consensus statement. Clin Genet. 2021. https:\/\/doi.org\/10.1111\/cge.14027.","journal-title":"Clin Genet"},{"key":"2246_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.639319","volume":"12","author":"HE Goldstein","year":"2021","unstructured":"Goldstein HE, Hauptman JS. The putative role of mTOR inhibitors in non-tuberous sclerosis complex-related epilepsy. Front Neurol. 2021;12: 639319. https:\/\/doi.org\/10.3389\/fneur.2021.639319.","journal-title":"Front Neurol"},{"key":"2246_CR5","unstructured":"International Society for the Study of Vascular Anomalies. ISSVA classification for vascular anomalies. Revised 2018.\nhttps:\/\/www.issva.org\/UserFiles\/file\/ISSVA-Classification-2018.pdf"},{"issue":"Pt 6","key":"2246_CR6","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/brain\/awv045","volume":"138","author":"LA Jansen","year":"2015","unstructured":"Jansen LA, Mirzaa GM, Ishak GE, et al. PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain. 2015;138(Pt 6):1613\u201328. https:\/\/doi.org\/10.1093\/brain\/awv045.","journal-title":"Brain"},{"issue":"2","key":"2246_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ajmg.a.36836","volume":"167A","author":"KM Keppler-Noreuil","year":"2015","unstructured":"Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287\u201395. https:\/\/doi.org\/10.1002\/ajmg.a.36836.","journal-title":"Am J Med Genet A"},{"issue":"7","key":"2246_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/ajmg.a.36552","volume":"164A","author":"KM Keppler-Noreuil","year":"2014","unstructured":"Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713\u201333. https:\/\/doi.org\/10.1002\/ajmg.a.36552.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2246_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ajhg.2019.09.002","volume":"105","author":"SN McNulty","year":"2019","unstructured":"McNulty SN, Evenson MJ, Corliss MM, et al. Diagnostic utility of next-generation sequencing for disorders of somatic mosaicism: a five-year cumulative cohort. Am J Hum Genet. 2019;105(4):734\u201346. https:\/\/doi.org\/10.1016\/j.ajhg.2019.09.002.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2246_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamaneurol.2016.0363","volume":"73","author":"G Mirzaa","year":"2016","unstructured":"Mirzaa G, Campbell CD, Solovieff N, et al. Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. 2016;73(7):836\u201345. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0363.","journal-title":"JAMA Neurol"},{"key":"2246_CR11","unstructured":"Mirzaa G, Graham JM Jr, Keppler-Noreuil K.\nPIK3CA-related segmental overgrowth. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews\u00ae. Seattle (WA); 2013 (updated December 23, 2021). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK153722\/pdf\/Bookshelf_NBK153722.pdf."},{"issue":"2","key":"2246_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajmg.a.34402","volume":"158A","author":"G Mirzaa","year":"2012","unstructured":"Mirzaa G, Conway RL, Gripp KW, et al. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A. 2012;158A(2):269\u201391. https:\/\/doi.org\/10.1002\/ajmg.a.34402.","journal-title":"Am J Med Genet A"},{"key":"2246_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87623","author":"G Mirzaa","year":"2016","unstructured":"Mirzaa G, Timms AE, Conti V, et al. PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight. 2016. https:\/\/doi.org\/10.1172\/jci.insight.87623.","journal-title":"JCI Insight"},{"key":"2246_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-108093","author":"A Mussa","year":"2022","unstructured":"Mussa A, Leoni C, Iacoviello M, et al. Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants. J Med Genet. 2022. https:\/\/doi.org\/10.1136\/jmedgenet-2021-108093.","journal-title":"J Med Genet"},{"key":"2246_CR15","unstructured":"Novartis. 2021. PIQRAY\u00ae prescribing information. Retrieved from https:\/\/www.novartis.us\/sites\/www.novartis.us\/files\/piqray.pdf."},{"key":"2246_CR16","unstructured":"Novartis. 2022. VIJOICE\u00ae prescribing information. Retrieved from https:\/\/www.novartis.us\/sites\/www.novartis.us\/files\/vijoice.pdf."},{"issue":"5","key":"2246_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","volume":"21","author":"VER Parker","year":"2019","unstructured":"Parker VER, Keppler-Noreuil KM, Faivre L, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21(5):1189\u201398. https:\/\/doi.org\/10.1038\/s41436-018-0297-9.","journal-title":"Genet Med"},{"issue":"7711","key":"2246_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","volume":"558","author":"Q Venot","year":"2018","unstructured":"Venot Q, Blanc T, Rabia SH, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018;558(7711):540\u20136. https:\/\/doi.org\/10.1038\/s41586-018-0217-9.","journal-title":"Nature"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02246-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02246-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02246-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:02:07Z","timestamp":1661335327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02246-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2246"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02246-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}